Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Gabay Avraham | CFO | S Sale | — | $4.51 | $331K | filing |
| Jul 2, 2026 | Hexter Joshua | COO, CBO | S SaleOE | — | $4.46 | $611K | filing |
ORAMED PHARMACEUTICA (ORMP) insider trades
ORAMED PHARMACEUTICA (ORMP) insider trading activity (SEC Form 4). Over the trailing 90 days, ORMP insiders filed 0 purchases totalling $0 and 2 sales totalling $942K — net SELLING of $942K. Most recent filing: Jul 2, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
2
$942K
Net (90d)
-$942K
net selling
Most recent
Jul 2, 2026